Preclinical News and Research

RSS
Experimental drug dinaciclib may improve myeloid leukemia, myeloma therapies

Experimental drug dinaciclib may improve myeloid leukemia, myeloma therapies

GENFIT receives FDA Fast Track designation for GFT505 development program in NASH

GENFIT receives FDA Fast Track designation for GFT505 development program in NASH

Researchers conduct pioneering translational study on immediate antidepressant effect of DBS

Researchers conduct pioneering translational study on immediate antidepressant effect of DBS

Horizon Discovery, Sirion Biotech ink supply and distribution agreement

Horizon Discovery, Sirion Biotech ink supply and distribution agreement

NIAID awards Soligenix SBIR grant to further develop SGX943 for treatment of melioidosis

NIAID awards Soligenix SBIR grant to further develop SGX943 for treatment of melioidosis

University of Liège joins IMI programme to develop new antibiotics against Gram-negative pathogens

University of Liège joins IMI programme to develop new antibiotics against Gram-negative pathogens

Aerpio Therapeutics doses first patient in AKB-9778 Phase 2 trial for diabetic macular edema treatment

Aerpio Therapeutics doses first patient in AKB-9778 Phase 2 trial for diabetic macular edema treatment

Agenus closes previously announced acquisition of 4-Antibody

Agenus closes previously announced acquisition of 4-Antibody

Researchers identify effective target for human autoimmune disease

Researchers identify effective target for human autoimmune disease

UMMS launches Voyager Therapeutics to develop life-changing treatments for fatal diseases

UMMS launches Voyager Therapeutics to develop life-changing treatments for fatal diseases

Tamoxifen drug appears to kill fungus associated with deadly brain infection

Tamoxifen drug appears to kill fungus associated with deadly brain infection

Ligand Pharmaceuticals' total revenues for Q4 2013 increase 8% to $14.7 million

Ligand Pharmaceuticals' total revenues for Q4 2013 increase 8% to $14.7 million

Researchers introduce unique micro-robotic technique for tissue engineering and 3D printing

Researchers introduce unique micro-robotic technique for tissue engineering and 3D printing

Pitt’s CMI funds 6 research groups for Early Stage Medical Technology Research and Development

Pitt’s CMI funds 6 research groups for Early Stage Medical Technology Research and Development

Immunology professor receives 2014 Szent-Györgyi Prize for progress in cancer research from NFCR

Immunology professor receives 2014 Szent-Györgyi Prize for progress in cancer research from NFCR

Prions and their shadow proteins: an interview with Dr Jiri Safar, Co-Director of the National Prion Disease Pathology Surveillance Center

Prions and their shadow proteins: an interview with Dr Jiri Safar, Co-Director of the National Prion Disease Pathology Surveillance Center

Proprietary supplement improves cognitive processing speed of older adults

Proprietary supplement improves cognitive processing speed of older adults

Combination of etoposide with compounds that interfere with cell division improves therapeutic window for cancer treatments

Combination of etoposide with compounds that interfere with cell division improves therapeutic window for cancer treatments

TSRI scientists design artificial proteins as a candidate vaccine against RSV

TSRI scientists design artificial proteins as a candidate vaccine against RSV

Incyte enters into clinical trial collaboration agreement with Merck to evaluate safety of IDO1 inhibitor

Incyte enters into clinical trial collaboration agreement with Merck to evaluate safety of IDO1 inhibitor

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.